Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News
Retireful LLC Makes New $260,000 Investment in BioNTech SE (NASDAQ:BNTX)
Wall Street Analysts Predict a 25.59% Upside in BioNTech (BNTX): Here's What You Should Know
BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference | The Manila Times
One biotech stock is 'oncology powerhouse' with 40% upside, says Truist
BioNTech (NASDAQ:BNTX) Now Covered by Analysts at Truist Financial
Promising Oncology Pipeline and Financial Strength Drive BioNTech's Growth Prospects
Truist rates BioNTech a Buy, citing 40% upside potential with key 2025 readouts By Investing.com
Vaccine stocks rise in premarket trading amid a jump in number of flu cases By Investing.com
Moderna Jumps 11% on Covid and Bird Flu News, Outperforming Falling Nasdaq 100
BioNTech (NASDAQ:BNTX) Sees Strong Trading Volume - Time to Buy?
BioNTech Sees Unusually Large Options Volume (NASDAQ:BNTX)
Why Vaccine Stocks, Lucid (LCID) Are Rallying
Moderna stock gains on rising flu cases By Investing.com
Head-To-Head Review: Alector (NASDAQ:ALEC) and BioNTech (NASDAQ:BNTX)
Penn expecting $467M from COVID-19 vaccine royalty dispute - WHYY
Acuitas Fights GSK Claims on Pfizer, BioNTech's Covid-19 Shot
Franklin Resources Inc. Sells 4,996 Shares of BioNTech SE (NASDAQ:BNTX)
Biontech's $1.26B vaccine royalty settlement clears path forward | BioWorld
BioNTech to pay $467M in settlement agreement with University of Pennsylvania
BioNTech to Pay Up to $1.26 Billion in Covid-19 Vaccine Settlements With NIH, Penn | Morningstar
BioNTech Enters Into Settlements With U.S. Agency, UPenn Over COVID-19 Vaccine Royalties
BioNTech settles with U.S. agency, University of Pennsylvania over Covid vaccine royalties
BioNTech to Pay US, UPenn $1.3B in COVID Vaccine Royalties
BioNTech SE (NASDAQ:BNTX) Receives $140.76 Consensus Target Price from Brokerages
BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties | U.S. & World | gazette.com
BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties By Reuters
BioNTech SE (NASDAQ:BNTX) Receives Average Recommendation of "Moderate Buy" from Analysts
BioNTech (NASDAQ:BNTX) Stock Price Up 2.9% – Time to Buy?
Latest news
Bitcoin Price Action Muted: A Complete Guide on How to Buy Bitcoins in the UK
Week Ahead: Japanese CPI and the BoJ rate hike on the watch, All eyes on the Canada inflation and Trump inauguration